Skip to main content

Find Clinical Trials

Home
Conditions
Philadelphia Chromosome Positive

Clinical trial condition

Philadelphia Chromosome Positive

Explore clinical trials studying Philadelphia Chromosome Positive. Study availability and eligibility vary by location and protocol.

13 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Philadelphia Chromosome Positive trial results

Active, Not Recruiting

Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic Leukemia

NCT01424982

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Adult Acute Lymphoblastic Leukemia in Complete Remission, +28 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells With or Without NKTR-255 in Adults With Recurrent or Refractory B Cell Malignancies

NCT03233854

Conditions: B Acute Lymphoblastic Leukemia, Burkitt Lymphoma, CD19 Positive, +22 more
Locations: Stanford University, School of Medicine Palo Alto, California, United States

View Trial Details

Active, Not Recruiting

Pembrolizumab and Blinatumomab in Treating Participants With Recurrent or Refractory Acute Lymphoblastic Leukemia

NCT03512405

Conditions: CD19 Positive, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details